Home
Conditions
Stage IV Pancreatic Cancer

Clinical trial condition

Stage IV Pancreatic Cancer

Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

70 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer trial results

Completed

Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00095966

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00088894

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

NCT00397787

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

NCT00047307

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

NCT00028496

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer

NCT00028834

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00039403

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00075647

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Stage IV Pancreatic Cancer

Stage IV Pancreatic Cancer trial results

Related conditions